The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
The role of the EGFR signaling in tumor microenvironment
Abstract
The epidermal growth factor receptor (EGFR) family comprehends four different tyrosine kinases (EGFR, ErbB‐2, ErbB‐3, and ErbB‐4) that are activated following binding to epidermal growth factor (EGF)‐like growth factors. It has been long established that the EGFR system is involved in tumorigenesis. These proteins are frequently expressed in human carcinomas and support proliferation and survival of cancer cells. However, activation of the EGFR in non‐malignant cell populations of the neoplastic microenvironment might also play an important role in cancer progression. EGFR signaling regulates in tumor cells the synthesis and secretion of several different angiogenic growth factors, including vascular endothelial growth factor (VEGF), interleukin‐8 (IL‐8), and basic fibroblast growth factor (bFGF). Overexpression of ErbB‐2 also leads to increased expression of angiogenic growth factors, whereas treatment with anti‐EGFR or anti‐ErbB‐2 agents produces a significant reduction of the synthesis of these proteins by cancer cells. EGFR expression and function in tumor‐associated endothelial cells has also been described. Therefore, EGFR signaling might regulate angiogenesis both directly and indirectly. In addition, activation of EGFR is involved in the pathogenesis of bone metastases. Within the bone marrow microenvironment, cancer cells stimulate the synthesis of osteoclastogenic factors by residing stromal cells, a phenomenon that leads to bone destruction. It has been shown that EGFR signaling regulates the ability of bone marrow stromal cells to produce osteoclastogenic factors and to sustain osteoclast activation. Taken together, these findings suggest that the EGFR system is an important mediator, within the tumor microenvironment, of autocrine and paracrine circuits that result in enhanced tumor growth. J. Cell. Physiol. 214: 559–567, 2008. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 4×
“Osteoclasts are the specialized progeny of hemopoietic precursors committed to the monocyte/macrophage lineage that, upon appropriate stimuli, fuse by giving rise to mature bone resorbing cells (Boyle et al., 2003).”
BackgroundInfluentialEpidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Self-citationAngiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Olayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
Epidermal growth factor receptor (EGFR) signaling in cancer
Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., & Salomon, D. S. (2006) · Gene · doi:10.1016/j.gene.2005.10.018 · Cited by 2,038
Self-citationThe EGFR family and its ligands in human cancer
Yarden, Y. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00230-1 · Cited by 1,587
Deans, R. J., & Moseley, A. B. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00482-3 · Cited by 1,412
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256 · cited 1×
“In fact, it has been described that ErbB-2 signaling increases the levels of HIF-1a protein and VEGF mRNA expression through a PI3K/AKT dependent pathway (Laughner et al., 2001).”
BackgroundOSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-123-5-2600 · Cited by 933
Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth Factor
Schreiber, A. B., Winkler, M. E., & Derynck, R. (1986) · Science · doi:10.1126/science.2422759 · Cited by 838
Petit, A. M. V., Rak, J. W., Hung, M., Rockwell, P., Goldstein, N. I., FENDLY, B. M., & Kerbel, R. S. (1997) · Europe PMC (PubMed Central) · Cited by 836
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8132 · Cited by 698 · cited 1×
“However, the kinase domain of ErbB-3 contains substitutions of critical amino acids and therefore lacks kinase activity (Guy et al., 1994).”
BackgroundPerrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., Hicklin, D. J., Radinsky, R., & Dinney, C. P. (1999) · PubMed · Cited by 647
Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Fontanini, G., Cuccato, S., Placido, S. D., Bianco, A. R., & Tortora, G. (2001) · PubMed · Cited by 643
Herceptin acts as an anti-angiogenic cocktail
Izumi, Y., Xu, L., di Tomaso, E., Fukumura, D., & Jain, R. K. (2002) · Nature · doi:10.1038/416279b · Cited by 623
Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., Gritsko, T., Turkson, J., Kay, H., Semenza, G. L., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208719 · Cited by 576
Mechanism of Divergent Growth Factor Effects in Mesenchymal Stem Cell Differentiation
Kratchmarova, I., Blagoev, B., Haack-Sorensen, M., Kassem, M., & Mann, M. (2005) · Science · doi:10.1126/science.1107627 · Cited by 565
Gupta, D., Treon, S., Shima, Y., Hideshima, T., Podar, K., Tai, Y., Lin, B., Lentzsch, S., Davies, F., Chauhan, D., et al. (2001) · Leukemia · doi:10.1038/sj.leu.2402295 · Cited by 553
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536
Bruns, C. J., Solórzano, C. C., Harbison, M. T., Ozawa, S., Tsan, R. Z., Fan, D., Abbruzzese, J. L., Traxler, P. M., Buchdunger, E., Radinsky, R., et al. (2000) · PubMed · Cited by 532
Goldman, C. K., Kim, J., Wong, W. L., King, V, Brock, T., & Gillespie, G. Y. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.1.121 · Cited by 531
UDAGAWA, N., TAKAHASHI, N., AKATSU, T., SASAKI, T., YAMAGUCHI, A., KODAMA, H., MARTIN, T. J., & SUDA, T. (1989) · Endocrinology · doi:10.1210/endo-125-4-1805 · Cited by 492
Guise, T. A., & Mundy, G. R. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0323 · Cited by 472
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., You, E., Tang, X., Kim, H., Meyer, S., Han, S. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.030 · Cited by 471
Horwood, N. J. (1998) · Endocrinology · doi:10.1210/en.139.11.4743 · Cited by 461
Niida, S., Kaku, M., Amano, H., Yoshida, H., Kataoka, H., Nishikawa, S., Tanne, K., Maeda, N., Nishikawa, S.-I., & Kodama, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.293 · Cited by 444
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases
Carraway III, K. L., Weber, J. L., Unger, M. J., Ledesma, J., Yu, N., Gassmann, M., & Lai, C. (1997) · Nature · doi:10.1038/387512a0 · Cited by 394
Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4
Zhang, D., Sliwkowski, M. X., Mark, M., Frantz, G., Akita, R., Sun, Y., Hillan, K., Crowley, C., Brush, J., & Godowski, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9562 · Cited by 383
Tashjian, A. H., Voelkel, E. F., Lazzaro, M., Singer, F. R., Roberts, A. B., Derynck, R., Winkler, M. E., & Levine, L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4535 · Cited by 380
Ciardiello, F., Bianco, R., Damiano, V., Fontanini, G., Caputo, R., Pomatico, G., Placido, S. D., Bianco, A. R., Mendelsohn, J. M., & Tortora, G. (2000) · PubMed · Cited by 378
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
Normanno, N., Bianco, C., De Luca, A., Maiello, M. R., & Salomon, D. S. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100001 · Cited by 336
Self-citationCiardiello, F., Caputo, R., Damiano, V., Caputo, R., Troiani, T., Vitagliano, D., Carlomagno, F., Veneziani, B. M., Fontanini, G., Bianco, A. R., et al. (2003) · PubMed · Cited by 328
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
Harari, D., Tzahar, E., Romano, J., Shelly, M., Pierce, J., Andrews, G., & Yarden, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202631 · Cited by 318
Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression
Miao, H., Lee, P., Lin, H., Soker, S., & Klagsbrun, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0250com · Cited by 312
Biology of Osteoclast Activation in Cancer
Roodman, G. D. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3562 · Cited by 306
Maity, A. M., Pore, N., Lee, J. S. H., Solomon, D., & O’Rourke, D. M. (2000) · PubMed · Cited by 302
平田, 晃. (2004) · Medical Entomology and Zoology · Cited by 298
Ligands for ErbB-family receptors encoded by a neuregulin-like gene
Chang, H., Riese II, D. J., Gilbert, W., Stern, D. F., & McMahan, U. J. (1997) · Nature · doi:10.1038/387509a0 · Cited by 281
The ErbB Receptors and their Ligands in Cancer: An Overview
Normanno, N., Bianco, C., Strizzi, L., Mancino, M., Maiello, M., Luca, A., Caponigro, F., & Salomon, D. (2005) · Current Drug Targets · doi:10.2174/1389450053765879 · Cited by 275
Self-citationMorabito, A., De Maio, E., Di Maio, M., Normanno, N., & Perrone, F. (2006) · The Oncologist · doi:10.1634/theoncologist.11-7-753 · Cited by 274
Self-citationPore, N., Jiang, Z., Gupta, A., Cerniglia, G., Kao, G. D., & Maity, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3090 · Cited by 268
Hirata, A., Ogawa, S.-I., Kometani, T., Kuwano, T., Naito, S., Kuwano, M., & Ono, M. (2002) · PubMed · Cited by 256
Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer.
Southby, J., Kissin, M. W., Danks, J. A., Hayman, J., Moseley, J. M., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1990) · PubMed · Cited by 249
Liu, X.-H., Kirschenbaum, A., Yao, S., & Levine, A. C. (2005) · Endocrinology · doi:10.1210/en.2004-1167 · Cited by 240
Yen, L., You, X.-L., Al Moustafa, A.-E., Batist, G., Hynes, N. E., Mader, S., Meloche, S., & Alaoui-Jamali, M. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203685 · Cited by 230
Bancroft, C. C., Chen, Z., Yeh, J., Sunwoo, J. B., Yeh, N. T., Jackson, S., Jackson, C., & Van Waes, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10398 · Cited by 230
Krampera, M., Pasini, A., Rigo, A., Scupoli, M. T., Tecchio, C., Malpeli, G., Scarpa, A., Dazzi, F., Pizzolo, G., & Vinante, F. (2005) · Blood · doi:10.1182/blood-2004-09-3645 · Cited by 226
Inoue, K., Slaton, J. W., Perrotte, P., Davis, D. W., Bruns, C. J., Hicklin, D. J., McConkey, D. J., Sweeney, P., Radinsky, R., & Dinney, C. P. (2000) · PubMed · Cited by 225
Nemeth, J. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.1.17 · Cited by 221
Amin, D. N., Hida, K., Bielenberg, D. R., & Klagsbrun, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3387 · Cited by 220
The role of EGF-related peptides in tumor growth
Normanno, N. (2001) · Frontiers in Bioscience · doi:10.2741/a635 · Cited by 216
Self-citationKlos, K. S., Wyszomierski, S. L., Sun, M., Tan, M., Zhou, X., Li, P., Yang, W., Yin, G., Hittelman, W. N., & Yu, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4559 · Cited by 201
Regulation of Osteopontin Expression in Osteoblasts
SODEK, J., CHEN, J., NAGATA, T., KASUGAI, S., TODESCAN, R., LI, I. W. S., & KIM, R. H. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44633.x · Cited by 191
Ibbotson, K. J., Harrod, J., Gowen, M., D'Souza, S., Smith, D. D., Winkler, M. E., Derynck, R., & Mundy, G. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.7.2228 · Cited by 179
CLARK, B. R., & KEATING, A. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31044.x · Cited by 176
Cloning and Biological Activity of Epigen, a Novel Member of the Epidermal Growth Factor Superfamily
Strachan, L., Murison, J. G., Prestidge, R. L., Sleeman, M. A., Watson, J. D., & Kumble, K. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006935200 · Cited by 170
Neuropilin-1 in Human Colon Cancer
Parikh, A. A., Fan, F., Liu, W. B., Ahmad, S. A., Stoeltzing, O., Reinmuth, N., Bielenberg, D., Bucana, C. D., Klagsbrun, M., & Ellis, L. M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63772-8 · Cited by 169
von Minckwitz, G., Jonat, W., Fasching, P., du Bois, A., Kleeberg, U., Lück, H.-J., Kettner, E., Hilfrich, J., Eiermann, W., Torode, J., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-1720-2 · Cited by 167
Kim, S.-J., Uehara, H., Karashima, T., Shepherd, D. L., Killion, J. J., & Fidler, I. J. (2003) · PubMed · Cited by 161
Wen, X.-F., Yang, G., Mao, W., Thornton, A., Liu, J., Bast, R. C., & Le, X.-F. (2006) · Oncogene · doi:10.1038/sj.onc.1209685 · Cited by 159
Pore, N., Liu, S., Haas-Kogan, D. A., O’Rourke, D. M., & Maity, A. M. (2003) · PubMed · Cited by 151
Iivanainen, E., Nelimarkka, L. O., Elenius, V., Heikkinen, S.-M., Junttila, T. T., Sihombing, L., Sundvall, M., Määttä, J. A., Laine, V. J. O., Ylä‐Herttuala, S., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0939com · Cited by 150
Baker, C. H., Kedar, D. J., McCarty, M. F., Tsan, R. Z., Weber, K. L., Bucana, C. D., & Fidler, I. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64253-8 · Cited by 148
Differential Regulation of Tumor Angiogenesis by Distinct ErbB Homo- and Heterodimers
Yen, L., Benlimame, N., Nie, Z.-R., Xiao, D., Wang, T., Moustafa, A. A., Esumi, H., Milanini, J., Hynes, N. E., Pagès, G., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0084 · Cited by 146
Guise, T. A. (1998) · Endocrine Reviews · doi:10.1210/er.19.1.18 · Cited by 146
Huang, S. M., Li, J., & Harari, P. M. (2002) · PubMed · Cited by 145
Akagi, M., Kawaguchi, M., Liu, W., McCarty, M. F., Takeda, A., Fan, F., Stoeltzing, O., Parikh, A. A., Jung, Y. D., Bucana, C. D., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600811 · Cited by 133
Wang, K., Yamamoto, H., Chin, J. R., Werb, Z., & Vu, T. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403114200 · Cited by 131
Takahashi, N., MacDonald, B. R., Hon, J. K., Winkler, M., Derynck, R., Mundy, G. R., & Roodman, G. D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112677 · Cited by 120
Parikh, A. A., Liu, W. B., Fan, F., et al. (2003) · Cancer · doi:10.1002/cncr.11560 · Cited by 108
WEBER, K. L., Doucet, M., Price, J. E., Baker, C. H., Kim, S. J., & Fidler, I. J. (2003) · PubMed · Cited by 105
Yokoi, K., Sasaki, T., Bucana, C. D., Fan, D., Baker, C. H., Kitadai, Y., Kuwai, T., Abbruzzese, J. L., & Fidler, I. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1698 · Cited by 100
Normanno, N., Luca, A. D., Aldinucci, D., Maiello, M. R., Mancino, M., D’Antonio, A., Filippi, R. D., & Pinto, A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00956 · Cited by 99
Self-citationMbalaviele, G., Jaiswal, N., Meng, A., Cheng, L., van den Bos, C., & Thiede, M. A. (1999) · Endocrinology · doi:10.1210/endo.140.8.6880 · Cited by 99
Karashima, T., Sweeney, P., Slaton, J. W., Kim, S. J., Kedar, D. J., Izawa, J. I., Fan, Z., Pettaway, C. A., Hicklin, D. J., Shuin, T., et al. (2002) · PubMed · Cited by 96
Receptor tyrosine kinase expression in human bone marrow stromal cells
Satomura, K., Derubeis, A. R., Fedarko, N. S., Ibaraki, K., Kuznetsov, S. A., Rowe, D. W., Young, M. F., & Robey, P. G. (1998) · Journal of Cellular Physiology · Cited by 95
Xiong, S., Grijalva, R., Zhang, L., Nguyen, N., Pisters, P. W. T., Pollock, R. E., & Yu, D. (2001) · PubMed · Cited by 92
Kedar, D. J., Baker, C. H., Killion, J. J., Dinney, C. P., & Fidler, I. J. (2002) · PubMed · Cited by 92
Wu, W., Onn, A., Isobe, T., Itasaka, S., Langley, R. R., Shitani, T., Shibuya, K., Komaki, R. U., Ryan, A. J., Fidler, I. J., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0416 · Cited by 89
Sini, P., Wyder, L., Schnell, C., O’Reilly, T., Littlewood, A., Brandt, R., Hynes, N. E., & Wood, J. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1954 · Cited by 87
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
Angelucci, A., Gravina, G. L., Rucci, N., Millimaggi, D., Festuccia, C., Muzi, P., Teti, A. M., Vicentini, C., & Bologna, M. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01100 · Cited by 83
Arkonac, B. M., Foster, L. C., Sibinga, N. E. S., Patterson, C., Lai, K., Tsai, J., Lee, M.-E., Perrella, M. A., & Haber, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4400 · Cited by 80
Mahtouk, K., Jourdan, M., Vos, J. D., Hertogh, C., Fiol, G., Jourdan, É., Rossi, J., & Klein, B. (2003) · Blood · doi:10.1182/blood-2003-05-1510 · Cited by 79
Ueda, S.-I., Basaki, Y., Yoshie, M., Ogawa, K., Sakisaka, S., Kuwano, M., & Ono, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3684 · Cited by 72
Kim, H. S., Shin, H. S., Kwak, H. J., Cho, C., Lee, C. O., & Koh, G. Y. (2002) · The FASEB Journal · doi:10.1096/fj.02-0570fje · Cited by 66
Morelli, M. P., Cascone, T., Troiani, T., Tuccillo, C., Bianco, R., Normanno, N., Romano, M., Veneziani, B. M., Fontanini, G., Eckhardt, S. G., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20666 · Cited by 58
Self-citationNormanno, N., & Gullick, W. J. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01185 · Cited by 58
Self-citationYounes, M. N., Yigitbasi, O. G., Park, Y. W., Kim, S.-J., Jasser, S. A., Hawthorne, V. S., Yazici, Y. D., Mandal, M., Bekele, B. N., Bucana, C. D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4196 · Cited by 55
Niu, G., & Carter, W. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3155 · Cited by 51
Intra- and extracellular signaling by endothelial neuregulin-1
Iivanainen, E., Paatero, I., Heikkinen, S.-M., Junttila, T. T., Cao, R., Klint, P., Jaakkola, P., Cao, Y., & Elenius, K. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.042 · Cited by 50
Bianco, R., Caputo, R., Caputo, R., Damiano, V., Placido, S. D., Ficorella, C., Agrawal, S., Bianco, A. R., Ciardiello, F., & Tortora, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0497 · Cited by 49
Hirata, A., Uehara, H., Izumi, K., Naito, S., Kuwano, M., & Ono, M. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02496.x · Cited by 43
Giuliani, N., Colla, S., Morandi, F., & Rizzoli, V. (2004) · PubMed · Cited by 33
Drake, M. T., Baldassare, J. J., McConkey, C. L., González, E. A., & Martin, K. J. (1994) · Endocrinology · doi:10.1210/en.134.4.1733 · Cited by 22
Cited by
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, A., Pawlicki, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910383 · Cited by 2,775
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
EGFR Mutations and Lung Cancer
da Cunha Santos, G., Shepherd, F. A., & Tsao, M. S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130206 · Cited by 949
Targeting the EGFR signaling pathway in cancer therapy
Seshacharyulu, P., Ponnusamy, M. P., Haridas, D., Jain, M., Ganti, A. K., & Batra, S. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.648617 · Cited by 913
Protein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Metadata
- Authors
- De Luca, A., Carotenuto, A., Rachiglio, A., Gallo, M., Maiello, M. R., Aldinucci, D., Pinto, A., & Normanno, N.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2007-09-25
- Volume
- 214
- Issue
- 3
- Pages
- 559-567
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2108882588
- Cited by
- 359
- References
- 98
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.